Drug Safety and Availability
Information for consumers and health professionals on new drug warnings and other safety information, drug label changes, and shortages of medically necessary drug products.
Drug Safety Communications
- FDA Drug Safety Communication: FDA revises description of mental health side effects of the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) to reflect clinical trial findings
- La FDA revisa la descripción de los efectos secundarios para la salud mental de los medicamentos para dejar de fumar Chantix (vareniclina) y Zyban (bupropión) para reflejar las conclusiones de estudio clínico
- FDA Drug Safety Communication: FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women
Drug Recalls
- Huvepharma, Inc. Issues Voluntary Nationwide Recall of Duramycin-10 Due to Stability Failure
- MS Bionic, Inc. Issues a Voluntary Nationwide Recall of All Lots of Megajex Natural Male Sex Enhancer Dietary Supplement
- Raritan Pharmaceuticals Inc. Issues a Voluntary Nationwide Recall of Products Containing Belladonna Extract Due to the Possibility of the Presence of Belladonna Alkaloids
Drug Safety Labeling Changes
Drug Shortages
Subscribe
Sign up to receive emails about Recalls
